165 related articles for article (PubMed ID: 38267301)
1. Impact of variant histology on upstaging and survival in patients with nonmuscle invasive bladder cancer undergoing radical cystectomy.
McFadden J; Tachibana I; Adra N; Collins K; Cary C; Koch M; Kaimakliotis H; Masterson TA; Rice KR
Urol Oncol; 2024 Mar; 42(3):69.e11-69.e16. PubMed ID: 38267301
[TBL] [Abstract][Full Text] [Related]
2. Oncologic outcomes of intravesical therapy in the management of nonmuscle invasive bladder cancer with variant histology.
Lone Z; Benidir T; Wood A; Campbell RA; Alaghehbandan R; Li J; Haber GP; Eltemamy M; Haywood SC; Weight CJ; Lee BH; Almassi N
Urol Oncol; 2024 Mar; 42(3):71.e1-71.e7. PubMed ID: 38135626
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Lymphovascular Invasion on Risk of Upstaging and Lymph Node Metastasis at the Time of Radical Cystectomy.
Werntz RP; Smith ZL; Packiam VT; Smith N; Steinberg GD
Eur Urol Focus; 2020 Mar; 6(2):292-297. PubMed ID: 30297221
[TBL] [Abstract][Full Text] [Related]
4. Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome.
Turker P; Bostrom PJ; Wroclawski ML; van Rhijn B; Kortekangas H; Kuk C; Mirtti T; Fleshner NE; Jewett MA; Finelli A; Kwast TV; Evans A; Sweet J; Laato M; Zlotta AR
BJU Int; 2012 Sep; 110(6):804-11. PubMed ID: 22321341
[TBL] [Abstract][Full Text] [Related]
5. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
[TBL] [Abstract][Full Text] [Related]
6. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M
Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy.
Claps F; van de Kamp MW; Mayr R; Bostrom PJ; Shariat SF; Hippe K; Bertz S; Neuzillet Y; Sanders J; Otto W; van der Heijden MS; Jewett MAS; Stöhr R; Zlotta AR; Trombetta C; Eckstein M; Mertens LS; Burger M; Soorojebally Y; Wullich B; Bartoletti R; Radvanyi F; Pavan N; Sirab N; Mir MC; Pouessel D; van der Kwast TH; Hartmann A; Lotan Y; Bussani R; Allory Y; van Rhijn BWG
BJU Int; 2023 Aug; 132(2):170-180. PubMed ID: 36748180
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of variant histology in bladder cancer: Would early and aggressive treatment shift the paradigm?
Ramos P; Mateus A; Manso M; Botelho F; Silva A; Silva J; Silva C; Pacheco-Figueiredo L
Urol Oncol; 2024 May; 42(5):161.e1-161.e8. PubMed ID: 38267300
[TBL] [Abstract][Full Text] [Related]
9. Histological variants of non-muscle invasive bladder cancer: Survival outcomes of radical cystectomy vs. bladder preservation therapy.
Dursun F; Elshabrawy A; Wang H; Wu S; Liss MA; Kaushik D; Grosser D; Svatek RS; Mansour AM
Urol Oncol; 2022 Jun; 40(6):275.e1-275.e10. PubMed ID: 35351370
[TBL] [Abstract][Full Text] [Related]
10. Molecular Subtyping of Clinically Localized Urothelial Carcinoma Reveals Lower Rates of Pathological Upstaging at Radical Cystectomy Among Luminal Tumors.
Lotan Y; Boorjian SA; Zhang J; Bivalacqua TJ; Porten SP; Wheeler T; Lerner SP; Hutchinson R; Francis F; Davicioni E; Svatek RS; Chen CL; Black PC; Gibb EA
Eur Urol; 2019 Aug; 76(2):200-206. PubMed ID: 31092337
[TBL] [Abstract][Full Text] [Related]
11. Detection and resection of carcinoma in situ of the bladder: Implications for clinical trial design.
Roumiguié M; Wong A; Belanger E; Wang G; Black PC
Urol Oncol; 2023 May; 41(5):254.e9-254.e15. PubMed ID: 36566105
[TBL] [Abstract][Full Text] [Related]
12. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
Babjuk M; Böhle A; Burger M; Capoun O; Cohen D; Compérat EM; Hernández V; Kaasinen E; Palou J; Rouprêt M; van Rhijn BWG; Shariat SF; Soukup V; Sylvester RJ; Zigeuner R
Eur Urol; 2017 Mar; 71(3):447-461. PubMed ID: 27324428
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of urothelial carcinoma ambiguous for muscularis propria invasion on initial transurethral resection of bladder tumor.
Hassan O; Murati Amador B; Lombardo KA; Salles D; Cuello F; Marwaha AS; Daniels MJ; Kates M; Bivalacqua TJ; Matoso A
World J Urol; 2020 Feb; 38(2):389-395. PubMed ID: 31030230
[TBL] [Abstract][Full Text] [Related]
14. Impact of High-risk Features and Effect of Neoadjuvant Chemotherapy in Urothelial Cancer Patients with Invasion into the Lamina Propria on Transurethral Resection in the Absence of Deep Muscle Invasion.
Metcalfe MJ; Ferguson JE; Li R; Xiao L; Guo CC; Czerniak BA; Siefker-Radtke A; Pretzsch SM; Navai N; McConkey DJ; Kamat AM; Campbell M; Dinney C
Eur Urol Focus; 2017 Dec; 3(6):577-583. PubMed ID: 28753816
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy.
Li Q; Assel M; Benfante NE; Pietzak EJ; Herr HW; Donat M; Cha EK; Donahue TF; Bochner BH; Dalbagni G
Eur Urol Focus; 2019 Jan; 5(1):104-108. PubMed ID: 28753857
[TBL] [Abstract][Full Text] [Related]
16. Predictors of adequate lymph node dissection in patients with non-muscle invasive bladder cancer undergoing radical cystectomy and effect on survival.
Lenis AT; Lec PM; Michel J; Brisbane W; Golla V; Sharma V; Gollapudi K; Blumberg J; Chamie K
Urol Oncol; 2020 Oct; 38(10):796.e7-796.e14. PubMed ID: 32446641
[TBL] [Abstract][Full Text] [Related]
17. Impact of Variant Histology on Occult Nodal Metastasis after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Review of the National Cancer Database.
Fu M; Klose C; Sparks A; Whalen M
Clin Genitourin Cancer; 2022 Apr; 20(2):e135-e139. PubMed ID: 34961704
[TBL] [Abstract][Full Text] [Related]
18. [Radical cystectomy in patients with non-muscle invasive bladder cancer who fail BCG therapy].
Huguet J; Gaya JM; Sabaté S; Palou J; Villavicencio H
Actas Urol Esp; 2010 Jan; 34(1):63-70. PubMed ID: 20223134
[TBL] [Abstract][Full Text] [Related]
19. Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy.
Ark JT; Keegan KA; Barocas DA; Morgan TM; Resnick MJ; You C; Cookson MS; Penson DF; Davis R; Clark PE; Smith JA; Chang SS
BJU Int; 2014 Jun; 113(6):894-9. PubMed ID: 24053444
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome and quality of life in octogenarian patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy or transurethral resection of the bladder tumor: a retrospective analysis of 143 patients.
Rehme C; Fritsch B; Thomas L; Istin S; Burchert C; Hummel B; Baleanu-Curaj B; Reis H; Szarvas T; Ruebben H; Hadaschik B; Niedworok C
Int Urol Nephrol; 2022 Jan; 54(1):71-79. PubMed ID: 34817753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
